Abstract
Soon after the epidemic of acquired immune deficiency syndrome (AIDS) began in the United States the preponderance of cases was found to be in two groups of individuals, homosexual men (CDC, 1981) and intravenous drug abusers (Wormser et al., 1983). This unusual distribution suggested hepatitis B as a possible model of transmission for proposed infectious agents. The occurrence of this syndrome in patients who had received blood products soon added additional support to that model. The Centers for Disease Control (CDC) received the first report of a haemophilia patient with Pneumocystis carinii pneumonia in January of 1982 and the second and third patients were found by the CDC through routine surveillance of requests in June and July of 1982 for drugs available only from CDC to treat P. carinii pneumonia (CDC, 1982a). Inquiries concerning these initial patients’ sexual activities, drug usage, ethnicity and travel or residence provided little evidence that the disease could have been acquired by contact with homosexuals, illicit drug abusers or Haitian immigrants. The hypothesis that AIDS developed in these patients as a result of an infectious agent transmitted by the blood products’ administration seemed logical and research for the occurrence of disease in transfusion recipients intensified. Soon it became clear that AIDS was a major problem for blood banks and the plasma industry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aledort, L. M., Levine, P. H., Hilgartner, M. et al. (1985) A study of liver biopsies and liver disease among haemophiliacs. Blood, 66, 367–72.
Allen, J. R. et al. (1985) HTLV-III antibody screening in a blood bank: Laboratory and clinical correlations. Proceedings of Workshop on Experience with HTLV-III Antibody Testing, sponsored by FDA, NIH and CDC, July 31.
Ammann, A. J., Cowan, M. J., Wara, D. W. et al. (1983) Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet, i, 956–8.
Beeson, P. B. (1943) Jaundice occurring one to four months after transfusion of blood or plasma: report of seven cases. JAMA, 121, 1332–4.
Carlson, J. R., Bryant, M. L., Hinrichs, S. H. et al. (1985) AIDS serology testing in low- and high-risk groups. JAMA, 253, 3405.
CDC (1981) Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men — New York City and California. MMWR, 30, 305.
CDC (1982a) Pneumocystis carinii pneumonia among persons with hemophilia A. MMWR, 31, 365–7.
CDC (1982b) Acquired immune deficiency syndrome (AIDS): Precautions for clinical and laboratory staffs. MMWR, 31, 577.
CDC (1983) Acquired immunodeficiency syndrome (AIDS): Precautions for healthcare workers and allied professionals. MMWR, 32, 450.
CDC (1984) Update: Acquired immunodeficiency syndrome (AIDS) in persons with hemophilia. MMWR, 33, 589.
CDC (1985a) Changing patterns of acquired immunodeficiency syndrome in hemophilia patients — United States. MMWR, 34, 241.
CDC (1985b) Update: Public Health Service workshop on human T-lymphotrophic virus type III antibody testing — United States. MMWR, 34, 477.
CDC (1985c) Testing donors of organs, tissues, and semen for antibody to human T-lymphotropic virus type III/lymphadenopathy-associated virus. MMWR, 34, 294.
CDC (1985d) Education and foster care of children infected with HTLV-III/LAV. MMWR, 34, 517.
CDC (1986a) Transfusion-associated human T-lymphotropic virus type III/lymphadenopathy-associated virus infection from a seronegative donor — Colorado. MMWR, 35, 389–91.
CDC (1986b) Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR, 35, 231–3.
CDC (1987) Acquired immunodeficiency syndrome (AIDS) weekly surveillance report — United States, June 15.
Chorba, T. L., Jason, J. M., Ramsey, R. B. et al. (1985) HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS. Thromb. Haemostas., 180–2.
Cohen, E. J., Strong, L. E., Hughes, W. I. Jr et al. (1946) Preparation and properties of serum and plasma proteins. IV: A system for the separation into fractions of protein and lipoprotein components of biological tissues and fluids. J. Am. Chem. Soc., 68, 459–75.
Colombo, M., Mannucci, P. M., Carnelli, V. et al. (1985) Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate. Lancet, ii, 1–4.
Curran, J. W., Lawrence, D. N., Jaffe, H. W. et al. (1984) Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N. Engl. J. Med., 310, 69–75.
Enck, R. E., Betts, R. F., Brown, M. R. et al. (1979) Viral serology (hepatitis B virus, cytomegalovirus, Epstein-Barr virus) and abnormal liver function tests in transfused patients with hereditary hemorrhagic diseases. Transfusion, 19, 32.
Evatt, B. L., Stein, S. F., Francis, D. P. et al. (1983) Antibodies to human T cell leukaemia virus-associated membrane antigens in haemophiliacs: Evidence for infection before 1980. Lancet, i, 698–701.
Evatt, B. L., Gomperts, E. D., McDougal, J. S. et al. (1985) Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic. N. Engl. J. Med.312, 483–6.
FDA (1985) Drug Bulletin. Progress on AIDS, 15, 27–32.
Felding, P., Nilsson, I. M., Hansson, B. G. and Biberfield, G. (1985) Absence of antibodies to LAV/HTLV-III in haemophiliacs treated with heat-treated factor VIII concentrate of American origin. Lancet, ii, 832–3.
Feorino, P. M., Kalyanaraman, V. S., Haverkos, H. W. et al. (1984) Lymphadenopathy associated virus infection of a blood donor-recipient pair with acquired immunodeficiency syndrome. Science, 225, 69–72.
Feorino, P. M., Jaffe, H. W., Palmer, E. et al. (1985) Transfusion-associated acquired immunodeficiency syndrome: Evidence for persistent infection in blood donors. N.Engl. J. Med., 312, 1293–6.
Gallo, R. C., Robert-Guroff, M. Kalyanaraman, V. S. et al. (1982) Human T-cell retrovirus and adult T-cell lymphoma and leukemia: possible factors on viral incidence, in Biochemical and Biological Markers of Neoplastic Transformation (ed. P. Chandra), Plenum Press, New York, pp. 503–13.
Gitschier, J., Wood, W. I., Goralka, T. M. et al. (1984) Characterization of the human factor VIII gene. Nature, Lond., 312, 326.
Groopman, J. E., Salahuddin, S. Z., Sarngadharan, M. G. et al. (1984) Virologic studies in a case of transfusion-associated AIDS. N. Engl. J. Med., 311, 1419–22.
Hay, C. R. M., Preston, F. E., Triger, D. R. and Underwood, J. C. E. (1985) Progressive liver disease in haemophilia: An understated problem? Lancet, i, 1495–8.
Heldebrant, C. M., Gomperts, E. D., Kasper, C. K. et al. (1985) Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentrates. Transfusion.25, 510–15.
HIE (1986) Hemophilia Information Exchange. Factor VIII product return recommended. Medical Bulletin no. 40.
Jaffe, H. W., Francis, D. P., McLane, M. F. et al. (1984) Transfusion-associated AIDS: Serologic evidence of human T-cell leukemia virus infection of donors. Science, 223, 1309–12.
Jaffe, H. W., Sarngadharan, M. G., DeVico, A. L. et al. (1985a) Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. J. AMA, 254, 770–3.
Jaffe, H. W., Feorino, P. M., Darrow, W. W. et al. (1985b) Persistent infection with human T-lymphotropic virus type III lymphadenopathy-associated virus in apparently healthy homosexual men. Ann. Intern. Med., 102, 627–30.
Jaye, M., De la Salle, H., Schamber, F. et al. (1983) Isolation of a human anti-haemophilic factor IX cDNA using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX. Nucl. Acids Res., 11, 2325.
Koeper, M. A., Kammsley, L. S. and Levy, J. A. (1985) Differential prevalence of antibody to AIDS-associated retrovirus in hemophiliacs treated with factor VIII concentrate versus cryoprecipitate: Recovery of infectious virus. Lancet, i, 275.
Kurachi, K. and Davie, E. W. (1982) Isolation and characterization of a cDNA coding for human factor IX. Troc. Natl Acad. Sci. USA, 79, 6461.
Kuritsky, J. (1985) Results of human T-lymphotropic virus type-Ill test kits reported from blood collection centers — United States: April 22-June 16, 1985. Proceedings of Workshop on Experience with HTLV-III Antibody Testing, sponsored by FDA, NIH and CDC, July 31.
Levine, P. (1985) AIDS in individuals with hemophilia. Ann. Intern. Med.103, 723–6.
Lui, K.J., Lawrence, D. N., Morgan, W. M. et al. (1986) A model-based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndrome. Proc. Soc. Natl Sci., 83, 3051–5.
McDougal, J. S., Jaffe, H. W., Cabradilla, C. D. et al. (1985a) Screeningtests for blood donors presumed to have transmitted the acquired immunodeficiency syndrome. Blood, 65, 772–5.
McDougal, J. S., Martin, L. S., Cort, S. P. et al. (1985b) Thermal inactivation of the AIDS virus, HTLV-III/LAV, with special reference to antihemophilic factor. J. Clin. Invest., 76, 875–7.
Mosseler, J., Schimpf, K., Auerswald, G. et al. (1985) Inability of pasteurised factor VIII preparations to induce antibodies to HTLV-III after long-term treatment. Lancet, i, 1111.
Okochi, K., Sato, H. and Hinuma, Y. (1984) A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang., 46, 245–53.
Oncley, J. L., Melin, M., Richert, D. A. et al. (1949) The separation of the antibodies isoagglutinins, prothrombin, plasminogen and beta-lipoprotein into subfractions of human plasma. J. Am. Chem. Soc., 71, 541–50.
Palmer, E., Sporborg, C., Harrison, A. et al. (1985) Morphology and immunoelectron microscopy of AIDS virus. Arch. Virol., 85, 189–96.
Prince, A. M., Horowitz, B. and Brotman, B. (1986) Sterilisation of hepatitis and HTLV-3 viruses by exposure to tri (n-butyl) phosphate and sodium cholate. Lancet, i, 706–10.
Ramsey, R. B., Palmer, E. L., McDougal, J. S. et al. (1984) Antibody to lym-phadenopathy-associated virus in haemophiliacs with and without AIDS. Lancet, i, 397–8.
Rouzioux, C., Chamaret, S., Montagnier, L. et al. (1985) Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated factor VIII concentrates. Lancet, ii, 271–2.
Schorr, J. B., Berkowitz, A., Cumming, P. O. et al. (1985) Prevalence of HTLV-III antibody in American blood donors. N. Engl. J. Med., 313, 384.
Soulier, J. P. (1984) Diseases transmitted by blood transfusion. Vox Sang, 47, 1–6.
Tedder, R. S., Uttley, A. and Cheingsong-Popov, R. (1985) Safety of immunoglobulin preparation containing anti-HTLV-III (letter). Lancet, i, 815.
Toole, J. J., Knopf, J. L., Wozney, J. M. et al. (1984) Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature, Lond., 312, 342.
van den Berg, W., ten Cate, J. W., Breederveld, C. and Goudsmit, J. (1986) Seroconversion to HTLV-III in haemophiliac given heat-treated factor VIII concentrate. Lancet, i, 803–4.
Vehar, G. A., Keyt, B., Eaton, D. et al. (1984) Structure of human factor VIII. Nature, Lond., 312, 337.
Wells, M. A., Wittek, A., Marcus-Sekura, C. et al. (1986) Chemical and physical inactivation of human T lymphotropic virus, type III (HTLV-III). Transfusion, 26, 110–30.
White, G. C., Matthews, T. J., Weinhold, K. J. et al. (1986) HTLV-III seroconversion associated with heat-treated factor VIII concentrate. Lancet, i, 611–12.
Wood, W. I., Capon, D. J., Simonsen, C. C. et al. (1984) Expression of active human factor VIII from recombinant DNA clones. Nature, Lond., 312, 330.
Wormser, G. P., Krupp, L. B., Hanrahan, J. P. et al. (1983) Acquired immunodeficiency syndrome in male prisoners. New insights into an emergency syndrome. Ann. Intern. Med., 98, 297–303.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Chorba, T.L., Evatt, B.L. (1987). Transfusion-associated AIDS. In: Madhok, R., Forbes, C.D., Evatt, B.L. (eds) Blood, Blood Products — and AIDS —. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3394-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3394-2_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-8018-3608-4
Online ISBN: 978-1-4899-3394-2
eBook Packages: Springer Book Archive